Asymmetrical ventricular enlargement in Parkinson's disease

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1657-1660

  Huang, Xuemei ^a   Lee, Yueh Z ^a   McKeown, Martin ^b   Gerig, Guido ^a,c   Gu, Hongbin ^a   Weill Lin, Phd ^a   Lewis, Mechelle M ^a   Ford, Sutapa ^a   Tröster, Alexander I ^a   Weinberger, Daniel R ^d   Styner, Martin ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c University of North Carolina   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Motor impairment; Parkinson's disease; Ventricle; Volume asymmetry

Indexed keywords

2BETA CARBOXYMETHOXY 3BETA (4 IODOPHENYL)TROPANE I 123; PRAMIPEXOLE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN VENTRICLE DILATATION; CASE REPORT; HUMAN; MONOZYGOTIC TWINS; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR;

ADULT; CEREBRAL VENTRICLES; DISEASES IN TWINS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; TWIN STUDIES AS TOPIC;

EID: 34748859370     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21626     Document Type: Article

References (12)

1. Lee CS, Schulzer M, Mak E, Hammerstad JP, Calne S, Calne DB. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurology 1995:45(3, Part 1):435-439.
2. Kumar A, Mann S, Sossi V, et al. [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain 2003;126 (Part 12):2648-2655.
3. Huber SJ, Miller H, Bohaska L, Christy JA, Bornstein RA. Asymmetrical cognitive differences associated with hemiparkinsonism. Arch Clin Neuropsychol 1992;7:471-480.
4. Tomer R, Sharon-Peretz J, Tsitrinbaum Z. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease. Neuropsychologia 2007;45:357-367.
5. Marie RM, Barre L, Rioux P, Allain P, Lechevalier B, Baron JC. PET imaging of neocortical monoaminergic terminals in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1995;9:55-71.
6. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 2001;108: 571-580.
7. Styner M, Lieberman JA, McClure RK, Weinberger DR, Jones DW, Gerig G. Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proc Natl Acad Sci USA 2005;102:4872-4877.
8. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127 (Part 3):550-560.
9. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
10. Van LK, Maes F, Vandermeulen D, Suetens P. Automated model-based bias field correction of MR images of the brain. IEEE Trans Med Imaging 1999;18:885-896.
11. Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006;31:1116-1128.
12. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006;129 (Part 4): 1040-1049.